UNASSIGNED: Status migrainosus is defined by the @entity2794 ( @entity2794 ) criteria as a debilitating @entity2704 lasting more then 72 hours. The epidemiology of @entity2704 is still unknown in adult and @entity1 , and frequently underdiagnosed. @entity1 and adolescents often end up in the emergency room with an intractable @entity10 that failed outpatient therapy. Six to seven percent of these @entity1 do not respond to acute infusion therapy and require hospitalization. It is imperative that more aggressive therapy is considered when @entity1 are affected by a severe intractable @entity10 to prevent further disability and returning the @entity1 to baseline activity. Multiple therapies are available for adults and @entity1 . Studies for acute therapy in the emergency room are available in adults and pediatric groups. Small studies are available for inpatient therapy in @entity1 and, along with available therapies for @entity1 and adolescents, are described in this review. A review of the literature shows growing evidence regarding the use of @entity3859 intravenously once @entity1 are hospitalized. Effectiveness and safety have been proven in the last decades in adults and small studies in the pediatric populations.

Pediatric inpatient XXXX therapy: What is available.

@entity1 :: ('9606', 'Species') :: ['children', 'patients', 'Children', 'child'] @entity2704 :: ('MESH:D008881', 'Disease') :: ['migraine', 'status migrainosus'] @entity2794 :: ('MESH:D020773', 'Disease') :: ['international classification of headache disorders', 'ICHD'] @entity3859 :: ('MESH:D004087', 'Chemical') :: ['dihydroergotamine'] @entity10 :: ('MESH:D006261', 'Disease') :: ['headache']
@entity10 :: (MESH:D006261,Disease) :: ['headache']
